Circular RNA PVT1 acts as a competing endogenous RNA for miR-497 in promoting non-small cell lung cancer progression
Authors:
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 111, 244-250
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Circular RNAs in cancer: opportunities and challenges in the fieldOncogene, 2017
- Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancerCancer Letters, 2017
- Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectivesOncotarget, 2016
- Circular RNA: A new star of noncoding RNAsCancer Letters, 2015
- MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung CancerCellular Physiology and Biochemistry, 2015
- Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancerBiochemical and Biophysical Research Communications, 2013
- MicroRNAs in CancerAnnual Review of Medicine, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Lung cancerThe Lancet, 2000
- Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria?Genes to Cells, 1998